miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis

by Madhumathy G Nair, Jyothi S Prabhu, Aruna Korlimarla, Savitha Rajarajan, Hari P S, Roma Kaul, Annie Alexander, Rohini Raghavan, Srinath B S, Sridhar T S
Published 2020-08-01

Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes

by Savitha Rajarajan, Savitha Rajarajan, Aruna Korlimarla, Aruna Korlimarla, Annie Alexander, C. E. Anupama, Rakesh Ramesh, B. S. Srinath, T. S. Sridhar, Jyothi S. Prabhu
Published 2021-06-01

HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells

by Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu, Madhumathy G Nair, Patrick Varun Lawrence, Aruna Korlimarla, Anupama CE, Annie Alexander, Rohini S Kaluve, Suraj Manjunath, Marjorrie Correa, BS Srinath, Shekhar Patil, Anjali Kalamdani, MSN Prasad, TS Sridhar
Published 2017-03-01

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease

by Jyothi S Prabhu, Aruna Korlimarla, C E Anupama, Annie Alexander, Rohini Raghavan, Roma Kaul, Krisha Desai, Savitha Rajarajan, Suraj Manjunath, Marjorrie Correa, R Raman, Anjali Kalamdani, MSN Prasad, Shekar Patil, K S Gopinath, B S Srinath, T.S. Sridhar
Published 2017-08-01